Teva Pharmaceuticals USA recalls

Teva Pharmaceuticals USA has 84 recalls on record with the FDA and USDA, the earliest in 2012 and the latest reported on 9 Sep 2026. 29 are still ongoing. 20 were reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls84since 2012

Last 12 months20reported

Class I22% of total

Ongoing29latest 9 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 1 0 0Apr 0 0 1Jul 0 0 0Oct 4 1 0Jan '26 0 4 9Apr 1 0 0Jul 0 1

Severity split

Class I 2 2%Class II 54 64%Class III 28 33%

Why teva pharmaceuticals usa is recalled

Product types

Brands

By year

20261518%
202578%
2024810%
20231012%
20221113%
201911%
201422%
20132530%
201256%

Ongoing teva pharmaceuticals usa recalls

29 active

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS II	traZODone Hydrochloride Tablets, USP, 50 mg recalledTrazodone Hydrochloride	Teva Pharmaceuticals USA	Other	Nationwide
13 May 2026Drug	CLASS II	Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate	Teva Pharmaceuticals USA	Sterility	Nationwide
29 Apr 2026Drug	CLASS II	Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) recalledClaravis	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
15 Apr 2026Drug	CLASS II	Isotretinoin Capsules, USP, 30 mg recalled by Teva Pharmaceuticals USAIsotretinoin	Teva Pharmaceuticals USA	Potency & Assay	4 states
15 Apr 2026Drug	CLASS II	Isotretinoin Capsules, USP, 40 mg Prescription Pacs recalledIsotretinoin	Teva Pharmaceuticals USA	Potency & Assay	4 states
15 Apr 2026Drug	CLASS II	Clonidine Transdermal System, USP, 3 mg/day, supplied recalledClonidine Transdermal System	Teva Pharmaceuticals USA	Manufacturing (CGMP) Deviations	NJ

All teva pharmaceuticals usa recalls, newest first

84 total

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS II	traZODone Hydrochloride Tablets, USP, 50 mg recalledTrazodone Hydrochloride	Teva Pharmaceuticals USA	Other	Nationwide
13 May 2026Drug	CLASS II	Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate	Teva Pharmaceuticals USA	Sterility	Nationwide
29 Apr 2026Drug	CLASS II	Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) recalledClaravis	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
15 Apr 2026Drug	CLASS II	Isotretinoin Capsules, USP, 30 mg recalled by Teva Pharmaceuticals USAIsotretinoin	Teva Pharmaceuticals USA	Potency & Assay	4 states
15 Apr 2026Drug	CLASS II	Isotretinoin Capsules, USP, 40 mg Prescription Pacs recalledIsotretinoin	Teva Pharmaceuticals USA	Potency & Assay	4 states
15 Apr 2026Drug	CLASS II	Clonidine Transdermal System, USP, 3 mg/day, supplied recalledClonidine Transdermal System	Teva Pharmaceuticals USA	Manufacturing (CGMP) Deviations	NJ
15 Apr 2026Drug	CLASS II	Clonidine Transdermal System, USP, 1 mg/day, supplied recalledClonidine Transdermal System	Teva Pharmaceuticals USA	Manufacturing (CGMP) Deviations	NJ
15 Apr 2026Drug	CLASS II	Clonidine Transdermal System, USP, 2 mg/day, supplied recalledClonidine Transdermal System	Teva Pharmaceuticals USA	Manufacturing (CGMP) Deviations	NJ
1 Apr 2026Drug	CLASS II	Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate	Teva Pharmaceuticals USA	Sterility	Nationwide
1 Apr 2026Drug	CLASS II	Octreotide Acetate for Injectable Suspension recalledOctreotide Acetate	Teva Pharmaceuticals USA	Sterility	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.